Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net loss	$ (991,487)	$ (2,933,571)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of debt discount	35,000	10,933
Preferred stock issued as compensation to employees, officers and/or directors	90,000
Preferred stock issued in exchange for fees and services	125,000
Derivative expense		102,248
Loss on change in value of derivative liabilities	448,598	2,592,696
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(145,000)
Accrued liabilities	164,565	162,807
Related party payables	1,549	4,924
Net cash used in operating activities	(271,775)	(59,963)
Cash flows from investing activities:
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock	199,380
Proceeds from issuance of preferred stock	60,000
Proceeds from issuance of convertible notes		60,000
Proceeds from issuance of short term loans	12,500
Net cash provided by financing activities	271,880	60,000
Net increase (decrease) in cash and cash equivalents	105	37
Cash and cash equivalents at beginning of period	111	19
Cash and cash equivalents at end of period	216	56
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued to reduce convertible and promissory notes payable	691,450
Series E preferred stock issued in lieu of cash for accrued officer compensation	$ 225,000